Clinical Operations & Strategy

>

Latest News

© Kaikoro - © Kaikoro - stock.adobe.com
AI-Powered Non-Interventional Research Delivers What DCTs Promised

August 8th 2025

A unified technology approach improves study efficiency and data collection.

Navigating Complexity: Strategies to Accelerate Modern Clinical Trials
Navigating Complexity: Strategies to Accelerate Modern Clinical Trials

August 5th 2025

© photon_photo - © photon_photo - stock.adobe.com
Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors

August 4th 2025

Rethinking Oncology Trials With a Statistical Methodology That Puts Patients First
Rethinking Oncology Trials With a Statistical Methodology That Puts Patients First

July 28th 2025

© JHVEPhoto - © JHVEPhoto - stock.adobe.com
FDA Crackdown on Trial Design: What July’s CRLs to Replimune and Capricor Mean for Sponsors

July 25th 2025

More News

i4-109172-1408709789668.jpg

Project Management Platform in an Academic Environment: The EORTC'S Promising Experience

August 1st 2004

A new, standard-based approach minimizes the delays between discovery of innovative agents and identification of their therapeutic benefit for patients-critical in cancer research.

Site Logo

Reconsidering Third-Party Companies for Subject Enrollment

Mary Anne Sabogal
April 1st 2004

Central call centers can relieve sites of tedious scheduling and record keeping, freeing them to focus on physical exams and other core tasks.

t1_tn-87247-1408713266588.jpg

Data Monitoring Committees in Practice

March 1st 2004

Subject safety in clinical trials has received much recent media attention, most publicly because of the death of a young man during a gene therapy study at the University of Pennsylvania.1 Some large and important clinical trials have been halted before their planned conclusions for safety and other concerns (for example, the Women's Health Initiative).2

<1
...
45678
© 2025 MJH Life Sciences

All rights reserved.